Abstract
The inhibition of SAPK2a/p38 (a mitogen activated protein (MAP) kinase family member) by SB 203580 depends on the presence of threonine at residue 106. Nearly all other protein kinases are insensitive to this drug because a more bulky residue occupies this site (Eyers et al., 1998). Raf is one of the few protein kinases that possesses threonine at this position, and we show that SB 203580 inhibits c-Raf with an IC50 of 2 μM in vitro. However, SB 203580 does not suppress either growth factor or phorbol ester-induced activation of the classical MAP kinase cascade in mammalian cells. One of the reasons for this is that SB 203580 also triggers a remarkable activation of c-Raf in vivo (when measured in the absence of the drug). The SB 203580-induced activation of c-Raf occurs without any increase in the GTP-loading of Ras, is not prevented by inhibitors of the MAPK cascade, protein kinase C or phosphatidylinositide 3-kinase, and is not triggered by the binding of this drug to SAPK2a/p38. The paradoxical activation of c-Raf by SB 203580 (and by another structurally unrelated c-Raf inhibitor) suggests that inhibitors of the kinase activity of c-Raf may not be effective as anti-cancer drugs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alessi DR. . 1997 FEBS Lett. 402: 121–123.
Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR. . 1995a J. Biol. Chem. 270: 27489–27494.
Alessi DR, Cohen P, Ashworth A, Cowley S, Leevers SJ and Marshall CJ. . 1995b Methods Enzymol. 235: 279–291.
Alessi DR, Anjelkovic M, Caudwell FB, Cron P, Morrice N, Cohen P and Hemmings BA. . 1996 EMBO J. 15: 6541–6551.
Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL and Griswold DE. . 1996 J. Pharmacol. Exp. Ther. 279: 1453–1461.
Bradford MM. . 1976 Anal. Biochem. 72: 248–254.
Burgering BM Th, Medema RH, Maassen JA, van de Wetering ML, van de Web AJ, McCormick F and Bos JL. . 1991 EMBO J. 10: 1103–1109.
Clifton AD, Young PR and Cohen P. . 1996 FEBS Lett. 392: 209–214.
Cohen P. . 1997 Trends Cell Biol. 7: 353–361.
Cohen P. . 1994 Biochem J. 303: 21–26.
Cross DAE, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS and Cohen P. . 1994 Biochem J 303: 21–26
Cuenda A, Rouse JR, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR and Lee JC. . 1995 FEBS Lett. 364: 229–231.
Doza YN, Hall-Jackson CA and Cohen P. . 1998 Oncogene 17: 19–24.
Eyers PA, Craxton M, Morrice N, Cohen P and Goedert M. . 1998 Chem. Biol. 5: 321–328.
Farrar MA, Alberola-Ila J and Perlmutter RM. . 1996 Nature 383: 178–181.
Gould GW, Cuenda A, Thomson FJ and Cohen P. . 1995 Biochem. J. 311: 735–738.
Goedert M, Cuenda A, Craxton M, Jakes R and Cohen P. . 1997 EMBO J. 16: 3563–3571.
Gum RJ, McLaughlin MM, Kumar S, Wang Z, Bower MJ, Lee JC, Adama JL, Livi GP, Goldsmith EJ and Young PR. . 1998 J. Biol. Chem. 273: 15605–15610.
Hazzalin CA, Cuenda A, Cano E, Cohen P and Mahadevan LC. . 1997 Oncogene 15: 2321–2331.
Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SF, Kern TS, Ballas LM, Heath WF, Stamm LE, Feener EP and King GL. . 1996 Science 272: 728–731.
Law NM and Lydon NB. . 1996 In: Emerging Drugs: The prospect for improved medicines. Ashley Publications Ltd pp. 241–261.
Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL and Young PR. . 1994 Nature 372: 739–746.
Leevers SJ, Paterson HF and Marshall CJ. . 1994 Nature 369: 411–414.
Luo Z, Tzivion G, Belshaw PJ, Vavvas D, Marshall M and Avruch J. . 1996 Nature 383: 181–185.
Morrison DK and Cutler RE. . 1997 Curr. Opin. Cell Biol. 9: 174–179.
Stokoe D, Macdonald SG, Cadwallader K, Symons M and Hancock JF. . 1994 Science 264: 1463–1467.
Tong L, Pav S, White DM, Rogers S, Crane KM, Cywin CL, Brown ML and Pargellis CA. . 1997 Nature Struct. Biol. 4: 311–316.
Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Yamagami K, Inui J, Maekawa M and Natumiya S. . 1997 Nature 389: 990–994.
Wilson KP, McCaffrey PG, Hsiao K, Pazhanisamy S, Galullo V, Bemis GW, Fitzgibbon MJ, Caron PR, Murcko MA and Su MSS. . 1997 Chem. Biol. 4: 423–431.
Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnell PC, Carr SA, Huddleston MJ, Seibel G, Porter TG, Livi GP, Adams JL and Lee JC. . 1997 J. Biol. Chem. 272: 12116–12121.
Acknowledgements
We thank Ulf Rapp for baculovirus vectors expressing Raf, Ras and Lck and Andrew Patterson for Sf9 cells expressing activated Raf. This work was supported by the UK Medical Research Council (PC and MG), the Royal Society (PC) and the Louis Jeantet Foundation (PC).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hall-Jackson, C., Goedert, M., Hedge, P. et al. Effect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene 18, 2047–2054 (1999). https://doi.org/10.1038/sj.onc.1202603
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202603
Keywords
This article is cited by
-
Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma
Scientific Reports (2020)
-
Inhibition of Neuronal p38α, but not p38β MAPK, Provides Neuroprotection Against Three Different Neurotoxic Insults
Journal of Molecular Neuroscience (2015)
-
Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization
Nature Chemical Biology (2013)
-
Combating Adaptation to Cyclic Stretching by Prolonging Activation of Extracellular Signal-Regulated Kinase
Cellular and Molecular Bioengineering (2013)
-
Murine Cytomegalovirus (MCMV) Infection Upregulates P38 MAP kinase in Aortas of Apo E KO Mice: a Molecular Mechanism for MCMV-Induced Acceleration of Atherosclerosis
Journal of Cardiovascular Translational Research (2013)